McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Read More…
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Phone972-446-4800
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$214.32 billion
Profitability
Miscellaneous
Employees80,000
Next Earnings Date10/30/2019 (Confirmed)
OptionableOptionable
McKesson (NYSE:MCK) Frequently Asked Questions
What is McKesson's stock symbol?
McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson pay dividends? What is the dividend yield for McKesson?
McKesson announced a quarterly dividend on Wednesday, July 31st. Investors of record on Tuesday, September 3rd will be given a dividend of $0.41 per share on Tuesday, October 1st. This represents a $1.64 dividend on an annualized basis and a yield of 1.11%. The ex-dividend date of this dividend is Friday, August 30th. This is a positive change from McKesson's previous quarterly dividend of $0.39. View McKesson's Dividend History.
How were McKesson's earnings last quarter?
McKesson Co. (NYSE:MCK) released its earnings results on Wednesday, July, 31st. The company reported $3.31 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $3.04 by $0.27. The company earned $55.73 billion during the quarter, compared to analyst estimates of $54.03 billion. McKesson had a net margin of 0.27% and a return on equity of 30.73%. The business's quarterly revenue was up 5.9% compared to the same quarter last year. During the same period last year, the company earned $2.90 EPS. View McKesson's Earnings History.
When is McKesson's next earnings date?
How can I listen to McKesson's earnings call?
McKesson will be holding an earnings conference call on Wednesday, October 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has McKesson issued on next quarter's earnings?
McKesson updated its FY20 earnings guidance on Wednesday, July, 31st. The company provided earnings per share (EPS) guidance of $14.00-14.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $14.12.
What price target have analysts set for MCK?
10 brokers have issued 1-year price targets for McKesson's shares. Their predictions range from $130.00 to $164.00. On average, they expect McKesson's stock price to reach $147.56 in the next twelve months. This suggests a possible upside of 0.1% from the stock's current price. View Analyst Price Targets for McKesson.
What is the consensus analysts' recommendation for McKesson?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.
Has McKesson been receiving favorable news coverage?
Headlines about MCK stock have trended somewhat positive on Monday, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. McKesson earned a news impact score of 0.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for McKesson.
Are investors shorting McKesson?
McKesson saw a decrease in short interest in September. As of September 15th, there was short interest totalling 5,190,000 shares, a decrease of 13.8% from the August 15th total of 6,020,000 shares. Based on an average trading volume of 1,520,000 shares, the days-to-cover ratio is currently 3.4 days. Currently, 2.8% of the shares of the stock are sold short. View McKesson's Current Options Chain.
Who are some of McKesson's key competitors?
What other stocks do shareholders of McKesson own?
Who are McKesson's key executives?
McKesson's management team includes the folowing people:
- Mr. John H. Hammergren, Chairman & CEO (Age 60)
- Britt J. Vitalone, CFO & Exec. VP (Age 50)
- Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
- Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
- Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)
Who are McKesson's major shareholders?
McKesson's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include PGGM Investments (0.28%), Robeco Institutional Asset Management B.V. (0.16%), Strs Ohio (0.12%), Meyer Handelman Co. (0.09%), Assenagon Asset Management S.A. (0.07%) and Zurcher Kantonalbank Zurich Cantonalbank (0.06%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, N Anthony Coles and Sundeep G Reddy. View Institutional Ownership Trends for McKesson.
Which major investors are selling McKesson stock?
MCK stock was sold by a variety of institutional investors in the last quarter, including Artemis Investment Management LLP, Heritage Investors Management Corp, Strs Ohio, Middleton & Co Inc MA, Gateway Investment Advisers LLC, Intellectus Partners LLC, Pacer Advisors Inc. and Meyer Handelman Co.. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs and Sundeep G Reddy. View Insider Buying and Selling for McKesson.
Which major investors are buying McKesson stock?
MCK stock was bought by a variety of institutional investors in the last quarter, including PGGM Investments, Assenagon Asset Management S.A., Robeco Institutional Asset Management B.V., Zurcher Kantonalbank Zurich Cantonalbank, Exane Derivatives, Beacon Harbor Wealth Advisors Inc., Meeder Asset Management Inc. and Calamos Advisors LLC. View Insider Buying and Selling for McKesson.
How do I buy shares of McKesson?
Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is McKesson's stock price today?
One share of MCK stock can currently be purchased for approximately $147.35.
How big of a company is McKesson?
McKesson has a market capitalization of $27.25 billion and generates $214.32 billion in revenue each year. The company earns $34 million in net income (profit) each year or $13.57 on an earnings per share basis. McKesson employs 80,000 workers across the globe.View Additional Information About McKesson.
What is McKesson's official website?
How can I contact McKesson?
McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]
MarketBeat Community Rating for McKesson (NYSE MCK)
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
